Previously: Olmsted syndrome 1 (OLS1)
Very painful, progressive, mutilating PPK, periorificial plaques, nail dystrophy, alopecia, erythromelalgia.
Very painful progressive, mutilating and incapacitating PPK, periorificial plaques, nail dystrophy, hair fragility and alopecia, milder but painful PPK phenotype
Erythromelalgia
EGFR inhibitors, e.g., Erlotinib (Greco, 2020; Zhang, 2020).
Lin Z, Chen Q, Lee M et al. Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome. Am J Hum Genet 2012; 90:558-64. | Duchatelet S, Pruvost S, de Veer S et al. A new TRPV3 missense mutation in a patient with Olmsted syndrome and erythromelalgia. JAMA Dermatol 2014; 150:303-6.
Summarised from published literature for general information. This is not medical advice, and entries are still being verified. Read the full disclaimer
This feature is coming soon.
This is a reference resource for clinicians and researchers. It is not medical advice or a diagnostic tool.
The database is still being verified and entries may be incomplete. Do not rely on it without independent professional judgement.
If you are a patient, parent or carer, please speak to your doctor about any symptoms or concerns.